The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Share News (PYC)

Share Price Information for Physiomics (PYC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.30
Bid: 1.20
Ask: 1.40
Change: -0.20 (-13.33%)
Spread: 0.20 (16.667%)
Open: 1.25
High: 1.30
Low: 1.05
Prev. Close: 1.50
PYC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Corcel rises on "shovel ready" Tring Road stake

Mon, 10th May 2021 10:19

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Corcel PLC, up 16% at 1.89 pence, 12-month range 0.7p-2.42p. Buys 40% stake in "shovel ready" Tring Road 50 megawatt gas peaking project outside of Aylesbury, England, from Arlington Energy Ltd. Purchase consideration is GBP400,000, to be satisfied by GBP150,000 in cash and 12.0 million new shares. "This is a highly significant milestone for Corcel. The addition of the 'shovel ready' Tring Road project to our existing Burwell project dramatically bolsters our position in the increasingly competitive flexible energy space here in the UK," says Chief Executive Scott Kaintz.

----------

Petro Matad, up 14% at 5.83p, 12-month range 2.16p-6.15p. Says Mineral Resources Professional Council will approve company's Heron field plan of development once certain technical clarifications have been provided and any resulting amendments to the documentation deemed necessary have been made. "With the recent relaxation of lockdown restrictions in Mongolia, the company is now in discussion with MRPC's designated officials to clarify the points raised in order to secure MRPC written approval of the Plan of Development," says Petro Matad.

----------

President Energy PLC, up 12% at 2.47p, 12-month range 1.1p-2.89p. The energy company says EV-1002, a new gas well as the Estancia Vieja field, has been successfully drilled, logged and cased on time and budget. Adds that LB-1002 well has now been placed on production and is performing better than pre-drilling expectations. Further, company says that average oil prices realised for first five months of 2021 are running 35% higher than for the full-year 2020. Gas prices also running higher.

----------

AIM - LOSERS

----------

Hurricane Energy PLC, down 9.7% at 0.7651p, 12-month range 0.72p-12.7p. The oil & gas company says average oil production rate for April at Lancaster field, located west of Shetland, Scotland, was lower than prior months. Output during April was 303,000 barrels from the P6 well and just 19,000 barrels from the 205/21a-7z well. This was lower than prior months, Hurricane Energy says, as the P6 well was producing on a standalone basis in line with the company's near-term production strategy. The P7z well produced for only nine days in the month for the purpose of well testing.

----------

Physiomics PLC, down 7.0% at 5.95p, 12-month range 3.55p-17.25p. Says results for current financial year to be below market expectations due to both pandemic-related project delays and an "increased focus on longer-term value-generating activities". Total income for year to June 30 to be in range of GBP700,000 to GBP800,000 and loss after tax around GBP170,000 to GBP200,000. "The pharmaceuticals and biotech industry has weathered the Covid storm better than many other sectors and industries, however it is not immune, and it is well known that trial delays have been a knock-on effect. We believe the impact on Physiomics will be temporary and we already see that clinical trials and patient recruitment are showing signs of returning to normality," says Chief Executive Jim Millen.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
23 Dec 2019 10:43

Physiomics Signs Further Project Agreement With CellCentric

Physiomics Signs Further Project Agreement With CellCentric

Read more
23 Dec 2019 08:33

Physiomics scores further project agreement with CellCentric

(Sharecast News) - Oncology consultancy business Physiomics has been awarded a further project agreement with British biotech outfit CellCentric.

Read more
20 Dec 2019 15:26

Merck Commits To Initial Contracts With Physiomics For 2020

Merck Commits To Initial Contracts With Physiomics For 2020

Read more
20 Dec 2019 11:27

Physiomics surges amid deepened Merck collaboration

(Sharecast News) - Shares of Physiomics leapt on Friday after it signed up to a £250,000 tranche of projects with pharmaceutical giant Merck and said trading was in line with expectations.

Read more
30 Sep 2019 16:06

Physiomics Achieves Record Annual Total Income And Narrows Loss

Physiomics Achieves Record Annual Total Income And Narrows Loss

Read more
30 Jul 2019 12:21

Physiomics Says Annual Performance In Line With Analyst Forecasts

(Alliance News) - Physiomics PLC on Tuesday said it traded in line with analyst expectations in its recently completed financial year.Shares in Physiomics were down 5.4% at 3.22 pence in to

Read more
8 Jul 2019 11:19

Physiomics Signs Agreement With Bicycle Therapeutics, Cancer Research

(Alliance News) - Medical prediction software developer Physiomics PLC said Monday it has signed an agreement with Nasdaq-listed biopharma firm Bicycle Therapeutics and research charity Cancer is

Read more
28 Jun 2019 10:56

Physiomics wins immune-oncology contract from Bicycle Therapeutics

(Sharecast News) - Cancer treatment technology provider Physiomics has been awarded a contract by Nasdaq-listed Bicycle Therapeutics, it announced on Friday.

Read more
14 May 2019 15:01

Physiomics Completes Innovate UK Prostate Cancer Grant Project

LONDON (Alliance News) - Physiomics PLC on Tuesday said it has completed its Innovate UK grant project and created a tool that can use routine blood tests to determine drug dosages for prostate in

Read more
20 Mar 2019 10:32

Physiomics To Meet With Potential Future Clients At AACR Conference

LONDON (Alliance News) - Physiomics PLC on Wednesday said it will use the opportunity of an upcoming conference to meet with current as well as potential future clients.Shares in the to the

Read more
21 Feb 2019 13:15

Physiomics Expects Strong Second Half As Loss Narrows, Revenue Rises

LONDON (Alliance News) - Physiomics PLC on Thursday reported a narrowed loss for the first half of its current financial year, helped by strong revenue growth.The AIM-listed company, which

Read more
21 Feb 2019 11:51

Physiomics narrows interim loss as revenue leaps

(Sharecast News) - Physiomics on Thursday reported a narrowed interim loss after the cancer monitoring technology provider more than doubled its revenue over the period.

Read more
17 Dec 2018 14:59

Physiomics collaboration with Merck to last another year

(Sharecast News) - Physiomics announced on Monday that, following a successful collaboration and pursuant to the master services agreement signed with US pharmaceuticals giant Merck in November last year, it had agreed with a programme of work for the next calendar year.

Read more
8 Oct 2018 09:55

Physiomics Annual Loss Halves, Revenue Doubles As New Momentum Emerges

LONDON (Alliance News) - Medical prediction software developer Physiomics PLC said Monday its full year loss halved as revenue doubled amid a "renewed" momentum at the firm.For to

Read more
9 Aug 2018 14:58

Physiomics wins small contract with European biotech client

(Sharecast News) - Cancer treatment prediction technology developer Physiomics has been awarded a contract by a new European biotech client, it announced on Thursday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.